Therapy: Clinical Trials

5 trials for Therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting, 1 completed, 1 terminated, 1 unknown. 5 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Not yet recruiting 2, Completed 1, Terminated 1, Unknown 1
Phase 32Not yet recruiting 1, Unknown 1

Follow Therapy: new trials by email Literature Review of Therapy trials Research Report on Therapy

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Melatonin Administration on Systemic Lupus Erythematosus Patients
Melatonin - Therapy, Treatment
Phase 2 / Phase 3Not yet recruitingAin Shams University642026-07-212026-07-23
Investigating the Therapeutic Efficacy of All-trans Retinoic Acid in Autism Spectrum Disorder Patients With 15q11-13 Duplication Syndrome
ATRA - Dup15q Syndrome, Autism Spectrum Disorder
Phase 2Not yet recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine902025-09-012025-07-23
Autologous Adipose-Derived Adult Stem Cell Implantation for Corneal Diseases (ADASCs-CT-CD)
Implantation, Lipoaspiration - Ophthalmological Disorder, Corneal Dystrophy
Phase 2CompletedVissum, Instituto Oftalmológico de Alicante152022-04-192023-05-06
Intrathecal Ketamine, Dexmedetomidine and Both With Bupivacaine for Postoperative Abdominal Cancer Surgery Pain
intrathecal drug administration, Dexmedetomidine, ketamine - Therapy, Pain Management
Phase 2 / Phase 3UnknownAssiut University902015-03-012015-05-28
Coriolus Versicolor as Palliative Therapy Compared to Placebo in Patients With Child-Pugh C Unresectable Hepatocellular Carcinoma
Coriolus Versicolor - Carcinoma, Therapy
Phase 2TerminatedNational University Hospital, Singapore202010-04-012014-01-14

Narrower conditions

Agnosia (1)  ·  Autism Spectrum Disorder (1)  ·  Carcinoma (1)  ·  Corneal Dystrophies, Hereditary (1)  ·  Eye Diseases (1)  ·  Fatigue (1)  ·  Inflammation (1)  ·  Keratoconus (1)  ·  Lupus Erythematosus, Systemic (1)  ·  Pain, Postoperative (1)

Broader conditions

Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Autoimmune Diseases (1)  ·  Child Development Disorders, Pervasive (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Connective Tissue Diseases (1)  ·  Corneal Diseases (1)  ·  Eye Diseases, Hereditary (1)  ·  Genetic Diseases, Inborn (1)  ·  Immune System Diseases (1)  ·  Mental Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Glandular and Epithelial (1)

Interventions

Bupivacaine (1)  ·  Dexmedetomidine (1)  ·  Drug Implants (1)  ·  Ketamine (1)  ·  Melatonin (1)

Sponsors

Ain Shams University (1)  ·  Assiut University (1)  ·  National University Hospital, Singapore (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)  ·  Vissum, Instituto Oftalmológico de Alicante (1)

Countries

China (1)  ·  Egypt (1)  ·  Singapore (1)  ·  Spain (1)

Top investigators

Ahmad M Abd El-Rahman, M.D. (1)  ·  Choo Su Pin, BMBS, MRCP, M Med (1)  ·  Jorge L Alio, MD, PhD (1)  ·  Tan Chee Kiat, MBBS, FRCP, FAMS (1)  ·  Wei Peng Yong, MRCP, MB ChB' (1)

Results publications

PMID 28486314, PMID 29103962, PMID 30772348, PMID 32301973, PMID 33164825, PMID 33181549, PMID 33591032, PMID 33708786, PMID 41126474

NIH funding

2018 (1)